PLSE

Pulse Biosciences, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website ulsebiosciences.com
Employees(FY) 61
ISIN US74587B1017

Performance

+4.9%

+5.52%

-4.0%

+57.72%

+46.9%

YTD

+56.35%

Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

Advanced Technical Analysis

Technical Analysis of PLSE 2024-12-20

The stock's indicators reflect a neutral sentiment, with the Moving Average Score at 50 indicating a balanced trend, while the Oscillators and Technical Scores at 43 and 46 suggest a slight bearish bias. Overall, the combined scores imply a cautious outlook for the stock, warranting close monitoring for potential shifts in momentum.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of PLSE

Stock Rank

Recent News & Updates

2024-12-19 08:00
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants(Business Wire)
2024-12-18 19:00
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants(Businesswire)
2024-12-18 06:26
Daily – Vickers Top Buyers & Sellers for 12/18/2024(Argus Research)
2024-12-17 08:00
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery(Business Wire)
2024-12-16 19:00
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery(Businesswire)
2024-12-16 05:32
Robert Duggan Spends US$972k On Pulse Biosciences Stock(Simply Wall St.)
2024-12-12 07:48
Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop(Simply Wall St.)
2024-11-26 14:47
Pulse Biosciences Stock Rises; Co-Chairman Duggan May Buy Shares(MT Newswires)
2024-11-15 06:14
Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans(Simply Wall St.)
2024-10-31 15:24
Pulse Biosciences New Treatment Study Shows Reduction of Benign Thyroid Nodules(MT Newswires)
2024-10-31 14:25
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association(Business Wire)
2024-10-31 13:58
Q3 2024 Pulse Biosciences Inc Earnings Call(Thomson Reuters StreetEvents)
2024-10-31 05:01
Pulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...(GuruFocus.com)
2024-10-31 02:25
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association(Businesswire)
2024-10-30 16:05
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results(Business Wire)
2024-10-30 16:02
Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology(Business Wire)
2024-10-30 04:05
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results(Businesswire)
2024-10-30 04:02
Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology(Businesswire)
2024-10-21 08:00
Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024(Business Wire)
2024-10-20 20:00
Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024(Businesswire)
2024-08-21 07:55
Better Cotton Pakistan, PULSE to boost data transparency in cotton farming(Just Style)
2024-08-13 12:38
Q2 2024 Pulse Biosciences Inc Earnings Call(Thomson Reuters StreetEvents)
2024-08-12 16:05
Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results(Business Wire)
2024-08-12 16:01
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors(Business Wire)
2024-08-12 04:05
Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results(Businesswire)
2024-08-12 04:01
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors(Businesswire)
2024-08-09 06:32
Pulse Biosciences launches first-in-human pulsed field ablation trial(Medical Device Network)
2024-08-08 08:00
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System(Business Wire)
2024-08-07 20:00
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System(Businesswire)
2024-08-01 16:05
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences(Business Wire)

Page 1 of 8

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.